Ligand validation:7DBM

DGT: 2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE

DGT is a Ligand Of Interest in 7DBM designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7DBM_DGT_C_601	62%	8%	0.15	0.944	3.34	1.41	13	6	1	0	100%	1
7DBM_DGT_A_601	57%	7%	0.178	0.954	3.34	1.47	13	6	0	0	100%	1
8X22_DGT_C_601	66%	6%	0.128	0.933	3.67	1.36	13	6	0	0	100%	1
6KDN_DGT_C_602	64%	6%	0.134	0.933	3.74	1.37	13	6	0	0	100%	1
5XN2_DGT_C_602	59%	6%	0.139	0.92	3.78	1.4	13	7	1	0	100%	1
6IK9_DGT_F_701	48%	6%	0.157	0.898	3.27	1.94	14	11	2	0	100%	1
2PYJ_DGT_A_1588	99%	33%	0.045	0.975	1.3	1.36	3	5	0	0	100%	1
3F2C_DGT_A_1456	99%	30%	0.06	0.989	0.96	1.8	1	6	13	0	100%	1
8ILD_DGT_A_201	98%	44%	0.057	0.982	0.9	1.26	1	5	0	0	100%	1
7U78_DGT_A_506	98%	44%	0.052	0.974	0.95	1.21	3	3	1	0	100%	0.85
3F2D_DGT_A_1456	98%	29%	0.065	0.985	0.96	1.84	-	7	11	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.